Media center
Press release
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
Owkin will use its clinical trial optimization solutions to bring OKN4395 to the patients most likely to benefit from this best-in-class therapeutic
May 23, 2024
Press release
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
Owkin will use its clinical trial optimization solutions to bring OKN4395 to the patients most likely to benefit from this best-in-class therapeutic
May 23, 2024
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
In the media
Bioptimus nabs $35M to accelerate biology research with AI
February 20, 2024
Bioptimus nabs $35M to accelerate biology research with AI
February 20, 2024
SiliconAngle
In the media
Bioptimus raises $35 million seed round to develop AI foundational model focused on biology
February 20, 2024
Bioptimus raises $35 million seed round to develop AI foundational model focused on biology
February 20, 2024
TechCrunch
In the media
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model
February 20, 2024
Google DeepMind alumni unveil Bioptimus: Aiming to build first universal biology AI model
February 20, 2024
VentureBeat
In the media
Salesforce and AWS step up to bolster AI safety and drug discovery
February 9, 2024
Salesforce and AWS step up to bolster AI safety and drug discovery
February 9, 2024
ERP Today
Press release
Owkin and AWS partner to advance GenAI for precision medicine
February 8, 2024
Owkin and AWS partner to advance GenAI for precision medicine
February 8, 2024
In the media
Owkin presentation, projects and future initiatives
February 8, 2024
Owkin presentation, projects and future initiatives
February 8, 2024
Radio Classique
In the media
10 ways to build a more intelligent future
January 17, 2024
10 ways to build a more intelligent future
January 17, 2024
Fast Company
In the media
Owkin Enters Into Collaboration Agreement With MSD To Develop AI-based Diagnostics For Cancer
January 6, 2024
Owkin Enters Into Collaboration Agreement With MSD To Develop AI-based Diagnostics For Cancer
January 6, 2024
Pathology News
In the media
Owkin and Evotec partner to accelerate therapeutics in oncology and I&I
January 5, 2024
Owkin and Evotec partner to accelerate therapeutics in oncology and I&I
January 5, 2024
PharmaTimes
Press release
Evotec and Owkin enter a strategic partnership to accelerate oncology and I&I therapeutics with AI
January 4, 2024
Evotec and Owkin enter a strategic partnership to accelerate oncology and I&I therapeutics with AI
January 4, 2024